Ask our AI-chatbot
Planned

Health Pilot

This is a preliminary announcement text. The text may be changed until the call opens for applications.

Important dates

13 Aug 2025

Open for applications

24 Sep 2025

Application deadline

Mid-December 2025

Expected response to application

01 Jan 2026

Earliest permitted project start

15 Aug 2026

Latest permitted project start

14 Aug 2030

Latest permitted project completion date

Important dates

Purpose

Through the Health Pilot scheme, we fund innovation processes that can contribute to sustainability in the health and care services and to value creation in Norwegian trade and industry, in line with Report No. 18 to the Storting (2018–2019) "The health industry – together on value creation and better services". The innovation processes must be based on the needs of patients, citizens or public health services.

About the call for proposals

Through effective collaboration, public and private actors can deliver better solutions to patients and citizens faster. The needs of the health services and the needs of the health industry are equally important within the Health Pilot scheme and must therefore be equally represented in the project. 

In the autumn of 2024, there was a mandatory call for pre-projects for this call. You must have completed a pre-project with funding from the Research Council in order to apply for a main project under this call.  

With this scheme, we aim to fund innovative projects that will make the health services more sustainable; that is, be able to offer safe, equal and adapted services of high quality to all citizens without increasing the overall burden on either the services or society. Furthermore, the services should be developed for both Norwegian and international markets. 

Summary page for Health Pilot

What characterises a Health Pilot project? 

A Health Pilot project shall: 

  • be based on recognised and specific needs within the specialist health service and/or the municipal health and care services that are either rooted in patients/residents or in the service itself 
  • be an ambitious innovation process with a high probability of future implementation and scalability, both nationally and internationally 
  • have collaboration between several actors across the public, private and possibly voluntary sectors that safeguard the users' perspective in a good way. It may be useful to include several service levels, as well as end users who can test the technologies or services developed within the project 

A Health Pilot project must: 

  • contain R&D activities that contribute to the development of innovative technologies, processes, products or services that offer solutions to well-defined and demonstrated needs 
  • include R&D activities that help ensure that these solutions can be implemented, commercialised and scaled after or in parallel with the R&D project 
  • be able to present clear potential to provide quantifiable benefits in both the public and private sectors 

Priorities for this call 

The call is open to all projects that aim to meet clear challenges in the specialist health service and/or the municipal health and care service that are either rooted in the needs of patients/residents or in the service itself. The needs must be validated through broad stakeholder involvement. We are looking for projects that aim to develop innovations that meet the challenges while at the same time contribute to sustainability in the health service and society in addition to creating value. 

By sustainability in the health service, we mean that in the future, the health services will continue to be able to offer safe, equal and adapted services of high quality to all citizens without increasing the overall burden on either the services, society or the environment. 

By innovations we mean new or significantly improved solutions, services, processes, organisational forms or marketing models that are used to create value and societal benefit. In order for the projects to contribute to value creation in Norwegian business and industry, the solutions developed should have a market both in Norway and abroad. 

In this call, priority will be given to Health Pilot projects that address the following topics: 

  • Innovations that provide personnel savings without compromising quality or productivity. Health Personnel Commission (NOU 2023: 4 - Tid for handling). 
  • Innovations that leverage existing, heavy infrastructure to ensure the ability to scale quickly. 
  • Interaction, task sharing and communication between service levels 
  • Recruiting healthcare personnel, creating attractive and resilient workplaces 
  • Develop innovative AI solutions for healthcare sustainability 
  • Self-service solutions to master one's own health, prevent illness and increase health literacy 
  • Projects that facilitate production in Norway 

Other challenges rooted in specific needs may also be relevant to Health Pilot projects. 

The call is available in both Norwegian and English. The text of the Norwegian call for proposals is legally binding. 

Who is eligible to apply?

It is a requirement that several partners are behind the application. The application must be submitted by the Project Owner on behalf of all partners in the collaboration consortium. The Project Owner must be either: 

  • a public sector enterprise with an organisation number in Norway and which represents the health and care sector (including municipalities). See the definition of public sector.  

or 

  • a business that is registered in the Norwegian Register of Business Enterprises and has economic activity in Norway 

Universities and university colleges cannot apply, i.e. be the Project Owner. 

Sole proprietorships, clusters, industry associations and technology transfer offices cannot be applicants. In other words, they cannot be the Project Owner or partners. 

Project employees who are to be paid by the project must be employed by the Project Owner or by one of the partners. 

Who can participate in the project?

Requirements for partners and roles 

If the Project Owner submitting the application is a company, collaboration with at least one public sector body that is registered with an organisation number in Norway is required. This enterprise must represent the health and care sector (municipalities are included). 

If the Project Owner is a public enterprise, collaboration with at least one enterprise that is registered in the Norwegian Register of Business Enterprises, and that has economic activity in Norway, is required. Sole proprietorships, clusters, industry associations and technology transfer offices cannot be partners. 

Collaborating partners enter into effective collaboration with the Project Owner, which means, among other things, that they share both the risk associated with the project and the results that emerge from it. They will also contribute with own financing. The collaborating partners and the Project Owner must enter into a consortium agreement. This agreement must govern the rights to use and commercial exploitation of the results. 

Norwegian and foreign research organisations, expert groups or R&D-performing companies may participate in the project as R&D providers, with responsibility for carrying out R&D work on behalf of the Project Owner and the collaborating partners. R&D providers are not required to contribute financially to the project and do not normally retain rights to the project results. They perform work on assignment at market rates. However, if they are to retain any rights to the results, the market value of those rights must be deducted from the price of the services they provide. 

Relevant user organisations, clusters, the voluntary sector, sole proprietorships and/or other relevant actors may participate in the project as subcontractors. The subcontractors' roles in the project must be described in the project description, and the costs must be entered in either the Project Owner or the collaborating partner's budget in the application. Sole proprietorships and limited liability companies without employees can only contribute to the project with smaller assignments. 

Note that the Project Owner and collaborating partners must be independent of each other, which means that one cannot have a controlling influence over the other. This aligns with the definition of partner in our General Terms and Conditions for R&D Projects, and with the definition of actual collaboration. Nor may R&D providers have a controlling influence over, or be controlled by, the Project Owner or partner. By controlling influence, we mean that one has a majority of shares or can otherwise control the other.    

It is the application with the relevant collaborating partners and R&D providers at the time of application that is the starting point for – and a decisive condition for – the allocation of funding. If you make changes to the project details before entering into a contract, funding can be withdrawn. 

Requirements relating to the project manager 

It is an advantage if the project manager has previous experience from public-private innovation collaboration. The project manager's professional competence and suitability to carry out the project will be assessed by the expert panel. 

Requirements for user participation 

User participation and user knowledge are usually important for success in innovation work. In this context, we mean patients and/or citizens, professional users/user organisations and/or those who will deliver the service (employees). In Health Pilot projects, we expect you to encourage user participation, and the user perspective should be clearly stated in the project description. If user participation is not included in the project, it must be clearly stated in the application why this is not relevant to your project. 

What can you seek funding for?

The Research Council's funding for Health Pilot projects is only to be used for R&D activities. In the project description, you must outline a plan for implementation, scaling and commercialisation, but we do not finance costs for these activities. 

Aid to companies and other enterprises (either as Project Owner or partner) constitutes state aid, and the R&D activities supported must be industrial research or experimental development as defined in the state aid rules (see "Article 25: Important definitions" on our state aid page). In the application form's progress plan, you must categorise the R&D activities by selecting either "Industrial research" or "Experimental development" from the drop-down menu.  

We do not provide support for activities of an operational nature and for measures to exploit the R&D results, such as protection of intellectual property rights, market research and marketing and production/completion of products and services to be marketed. 

Support to public actors must be allocated to R&D activities and to activities necessary for adapting the organisation, systems, and work processes to enable procurement and implementation of the developed solution(s) after the R&D project is completed. 

In the progress plan of the application form, you must mark the R&D activities as "Main activity". 

You can apply for funding to cover the following project costs that are actual costs and that are necessary to carry out the project: 

  • Payroll and indirect expenses 
  • Procurement of R&D  
  • Equipment 
  • Other operating expenses 

You will find detailed and important information about what to enter in the project budget on the website. All project costs must be budgeted in accordance with the Research Council's guidelines. 

We will not support undocumented costs, such as your own unpaid work. You must therefore not include such costs in the project budget. 

Scope of support 

The degree of funding for project expenses from public agencies is limited to 80 per cent of approved project expenses. 

The degree of support for the company's project expenses depends on the company's size and type of R&D activities. We do not provide additional support for actual collaboration. The aid intensity may therefore vary from 25 to 70 per cent, cf. the state aid rules (see Article 25: Aid for research and development projects, and the table below).  

Type of company/type of activity 

Industrial research 

Experimental development 

Small businesses 

70 % 

45 % 

Between companies 

60 % 

35 % 

Large companies 

50 % 

25 % 

For applications that receive funding, the support will be determined when we enter into a contract with you. You will receive an offer of a conditional grant allocation on the condition that the applicant revises the application in accordance with the allocation decision, cf. the bullet points below. 

Conditions for funding 

Projects must start between 1 January 2026 and 15 August 2026, and you must apply for funding from the Research Council from 2026. The latest permitted project completion date is 14 August 2030. 

Our conditions for funding can be found in the General Terms and Conditions for R&D Projects. For projects awarded funding under this call, financial reports documenting accrued project costs and funding sources must be submitted annually.  

We assume that the project is carried out in effective collaboration between the Project Owner and the collaborating partners. The Project Owner and the partners must enter into a consortium agreement that regulates the allocation of rights related to the use and commercial exploitation of the results. 

Support for a research organisation must go to the organisation's non-economic activity. It therefore does not constitute state aid. The Research Council assumes that the necessary accounting separation is in place. Aid to "undertakings" constitutes state aid. In this context, an undertaking means any actor that engages in economic activity by offering goods and/or services in a market. When an undertaking is to have part of its project costs covered, either as a Project Owner or as a partner in the project, this must be done in accordance with Article 25 of the General Block Exemption Regulation (Commission Regulation (EU) No 651/2014). Read more about state aid.  

The call for proposals has been notified as an aid scheme to the EFTA Surveillance Authority (ESA) and has the reference: GBER xx/202x/R&D&I (reference forthcoming). 

  • The scheme must be practised in accordance with the EEA Agreement's state aid rules. Terms and concepts shall be interpreted in accordance with the corresponding terms and concepts in the aid rules. In the event of any conflict between the announcement and the state aid rules, the latter shall take precedence. For the same reason, the call for proposals may also be adjusted. 
  • The aid that goes to companies is awarded in accordance with Article 25 of the General Block Exemption Regulation (Commission Regulation (EU) No 651/2014). In addition, the general conditions in Chapter I of the Regulation must be met. See the Consolidated Block Exemption Regulation with amendments up to and including July 2020.   
  • Aid may not be granted to undertakings that have not complied with the requirements for repayment following a previous decision by the ESA/EU Commission declaring the aid illegal and incompatible with the internal market. Nor may aid be granted to undertakings in difficulty within the meaning of EEA law. 
  • The companies participating in the project must submit a self-declaration confirming that they are eligible to receive state aid. 
  • State aid awarded of €500,000 or more will be published in the "Register of State Aid". 
  • Other public funding to cover the same eligible costs may affect the scope of the Research Council's funding. 
  • When the Project Owner knows that the project will be awarded funding, they must inform any partners that are listed on the Stock Exchange or have applied to be admitted to trading on the Oslo Stock Exchange, so that partners can assess whether the allocation of project funds constitutes market sensitive information. 

In addition, you must be aware of the following if you should receive an award from us: 

Please contact us if you have any questions

The contact persons below make up the reference group for the Health Pilot scheme. The persons represent the specialist and primary health services throughout the country. Feel free to contact us if you have any questions about whether your project is suitable for the purpose of the call, or if you need help contacting relevant professional environment/service level in the health service. 

Name 

Location 

Email 

Telephone 

Tine Thorbjørnsen 

The Research Council of Norway 

tth@forskningsradet.no   

41611585 

Siv Øverås 

The Research Council of Norway 

sio@forskningsradet.no 

  

Marit S. Bratlie 

Central Norway Regional Health Authority 

marit.bratlie@helse-midt.no  

  

Cille Hagland Sevild 

KSF Region West 

cille.sevild@stavanger.kommune.no  

  

Lena Forgaard 

Western Norway Regional Health Authority 

lena.forgaard@helse-vest.no  

  

Christian Skattum 

Oslo University Hospital 

Christian.Skattum@ous-hf.no  

  

Magnus Engeset 

University Hospital of North Norway 

magnus.engeset@unn.no 

  

Relevant thematic areas for this call

Health

Health, care and welfare services

Practical information

Requirements for this funding scheme

The application must be based on a pre-project submitted by the deadline of 16 October 2024. 

The application must be created and submitted via My RCN Web. You can change and submit the application several times until the application deadline. We recommend that you submit your application as soon as you have completed the application form and uploaded the required attachments. When the application deadline expires, it is the latest version of the application that we process. 

  • The application and all attachments must be written in Norwegian or English. You will find all application templates at the bottom of the call. 
  • All attachments must be in PDF format. 
  • Enter the 6-digit project number for your pre-project in the field "Other relevant programmes/activities/projects". 

Mandatory attachments 

  • Project description, maximum 15 pages. Use the default template that you can download at the bottom of the page. 
  • CV for the project manager and other key participants in the project. Use the default template that you can download at the bottom of the page. All CVs should be collected in a PDF file before it is uploaded. 
  • Letters of intent from partners 
  • Partner details (for companies only) 

Applications that do not meet the requirements above may be rejected. 

All attachments to the application must be submitted with the application. We do not accept attachments submitted after the application deadline unless we have requested additional documentation. 

We will not consider documents and websites linked to in the application, or attachments other than those specified above. Be careful to upload the correct attachment type, as there are no technical restrictions on what kind of templates it is possible to upload in the application form. 

Assessment criteria

Applications will be assessed in light of the purpose of the call and the following criteria:

Excellence

To what extent does the project represent an ambitious innovation that is supported by relevant and high-quality R&D activities?

• To what extent does the innovation represent something novel?
• To what extent will the innovation help to resolve a challenge and/or meet a recognised need in the health services?
• To what extent is the innovation targeted towards new market opportunities for the companies that are partners in the project?

• To what extent does the project build on relevant and updated knowledge?
• To what extent does the project employ relevant and recognised R&D methods?
• To what extent are the R&D activities essential for the success of the innovation?

Impact

To what extent does the project pave the way for benefits and value creation in public sector bodies and the Norwegian business sector, and form the basis for other positive impacts in society? To what extent are the potential impacts of the project clearly formulated and plausible?

• To what extent will the project entail a potential for sustainable value creation in the Norwegian business sector with significant economic benefits for companies?
• To what extent will the project form the basis for benefits and value creation in the health sector in the form of more sustainable health and care services?
• To what extent can the project generate other positive external effects for patients, inhabitants and society or in the form of knowledge dissemination?

• To what extent does the plan for implementation of the R&D results and realisation of benefits give reason to indicate that the project can achieve the impacts described? Is the plan relevant and appropriate, for example in relation to
- needs and plans for adapting the organisation, systems and/or work processes;
- needs and plans for investments and allocation of resources;
- management of IPR and regulatory approvals;
- development of business models and/or commercialisation plans incl. partnerships;
- risk assessments in relation to e.g. implementation and/or market access;
- dissemination and communication.

Implementation

To what extent do the project plan and the project group provide a good basis for implementing the R&D activities and utilising the results?

• To what extent does the R&D project plan incorporate appropriate and effective objectives, work packages, milestones, resources and relevant risk assessments?
• To what extent are the plans for user participation relevant and appropriate?

• To what extent does the project group have the competence and expertise necessary to ensure efficient implementation of the R&D project and with sufficient capacity?
• To what extent is the project strategically aligned with the partners and is the distribution of the budget, roles and responsibilities clearly defined and relevant?
• To what extent does the project manager have relevant expertise and experience to lead an R&D project targeted towards innovation and value creation through public-private collaboration?

• To what extent does the project group have the competence and capacity necessary to ensure utilisation of the R&D results and realisation of the benefits?

Administrative procedures

Once the application deadline has expired, we will first carry out a preliminary assessment to check that all formal requirements are met, first and foremost that the applicant has completed a pre-project. Applications that do not satisfy the formal requirements may be rejected. 

Applications will be distributed to external referees with relevant expertise. 

For each application, we check that the referees are impartial and have expertise in the application's thematic area. The referees assess the criteria "Excellence", "Impact ", "Implementation" and "Relevance to the call". The referees’ assessments are crucial importance for whether the project can be awarded funding. 

Decisions by the portfolio board 

The administration then submits the applications and assessments for decision to the Research Council's portfolio board for health. The portfolio board aims to balance the portfolio of projects within its areas of responsibility and the thematic priorities set out in the call, also in light of ongoing projects and any applications for other calls. These assessments will be based on budget frameworks, the call text, the portfolio plan and the letter of allocation from the Ministry of Health and Care Services. In particular, the Ministry has asked the Research Council to prioritise implementation and impact research. 

The portfolio board will also base its assessment on the Research Council's general policy for the allocation of funding, i.e. we will assess the applications based on 

  • Requirements for research ethics 
  • Prioritisation of projects based on their impact on sustainability and the environment among applications with equal quality assessment 

We expect to publish a list of applications that will receive funding in December 2025. 

See also: How we process applications.    

Messages at time of print 12 June 2025, 22:44 CEST

No global messages displayed at time of print.